Komori
Other Disclosures4069BlueMeme Inc.Information and Communications, Services and Others

BlueMeme Presents Joint Research Findings with Kyushu University at ASHG 2026, One of the World's Largest Human Genetics Conferences

Two joint research findings from BlueMeme and Kyushu University were accepted for poster presentations at ASHG 2026 and presented in person from 20 to 24 October 2026. The research findings concern transcription factor binding prediction using quantum machine learning and gene-level haplotype phasing using MAX-CUT.

Worth reading
60In focus
Scored from 5 of 6 sections
Direction
Improvement
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Conditional
How definitive the wording is.

Announced details

Quantum machine learning model QTFPred (Quantum-based Transcription Factor Predictor)Transcription factor binding prediction model using a GPU-efficient quantum machine learning implementationGene-level haplotype phasing using spectral MAX-CUT on a lead-level graph
Applicable field (uses covered by this announcement)
Drug DiscoveryPersonalized MedicineDisease risk predictionDrug target molecule discoveryGenomic analysisMedical and drug discovery research
Launch dateFrom 20 October 2026 to 24 October 2026 (actual; ASHG 2026 venue and poster presentations)
Relationship between the counterparty and the company
BlueMeme Inc.4069
Relationship with the Company

The company conducts joint research with the Nagasaki Laboratory at Kyushu University.

CounterpartyKyushu University, Institute of Health Sciences, Center for Deep Omics Science, Biomedical Information Analysis, Nagasaki Laboratory

The Biomedical Information Analysis division of the Center for Deep Omics Science, Institute of Health Sciences, Kyushu University. The person in charge is Professor Nagasaki Masao (長﨑 正朗).

Location (as indicated in this announcement)

Montreal, Canada: Palais des congrès de Montréal (venue for ASHG 2026)

In this announcement the company addresses none of Contract Value / Offering price / Impact on Business Performance.

Source (materials cited by the company)

Official website of the American Society of Human Genetics (ASHG) (https://ashgmeeting.ashg.org/)

Announced details
ItemDetails
Names of Products / Services CoveredQuantum machine learning model QTFPred (Quantum-based Transcription Factor Predictor), Transcription factor binding prediction model using a GPU-efficient quantum machine learning implementation, Gene-level haplotype phasing using spectral MAX-CUT on a lead-level graph
CounterpartyKyushu University, Institute of Health Sciences, Center for Deep Omics Science, Biomedical Information Analysis, Nagasaki Laboratory
Counterparty overviewThe Biomedical Information Analysis division of the Center for Deep Omics Science, Institute of Health Sciences, Kyushu University. The person in charge is Professor Nagasaki Masao (長﨑 正朗).
Relationship with the CompanyThe company conducts joint research with the Nagasaki Laboratory at Kyushu University.
Launch dateFrom 20 October 2026 to 24 October 2026 (actual; ASHG 2026 venue and poster presentations)
Applicable areaDrug Discovery, Personalized Medicine, Disease risk prediction, Drug target molecule discovery, Genomic analysis, Medical and drug discovery research
LocationMontreal, Canada: Palais des congrès de Montréal (venue for ASHG 2026)
SourceOfficial website of the American Society of Human Genetics (ASHG) (https://ashgmeeting.ashg.org/)
Items this document does not state (10)
Contract ValueOffering priceContract DateAward/certification nameAwarding / certifying bodyRegistration number and expiry dateLocation scaleQuantitative EffectsUsage historyImpact on Business Performance

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

To pursue the implementation in society and broad applications of quantum AI and genome analysis technologies through the publication of research findings, and to contribute to sustained technological innovation and the resolution of social issues.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
BlueMeme Presents Joint Research Findings with Kyushu University at ASHG 2026, One of the World's Largest Human Genetics Conferences | BlueMeme Inc. (4069) timely disclosure | Komori